Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Viking Therapeutics Inc. May 20, 202574.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +16,000 | $4.48 | $71,680 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +22,000 | $5.80 | $127,600 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +22,000 | $4.88 | $107,360 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Open-market sale | −60,000 | $35.57 | $2,134,200 |
| May 16, 2023 | Viking Therapeutics Inc. | Option exercise | +40,000 | $1.08 | $43,200 |
| May 16, 2023 | Viking Therapeutics Inc. | Open-market sale | −40,000 | $25.00 | $1,000,000 |
Questions about Charles A. Rowland Jr.
What boards is Charles A. Rowland Jr. on?
Charles A. Rowland Jr. sits on the board of Viking Therapeutics Inc.
How long has Charles A. Rowland Jr. served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.